PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea
Acquisition creates a world-class large-scale manufacturing hub in San Diego region with state-of-the-art aseptic facilities for prefilled syringes, cartridges and high potent formulations such as ADCs, complementing existing global sterile fill-finish and advanced drug delivery operations.
Article content
Article content
PHILADELPHIA — PCI Pharma Services ('PCI') – a leading global contract development and manufacturing organization (CDMO) focused on innovative biopharma therapies – is acquiring an entire equity stake in Ajinomoto Althea, Inc. ('Althea'), a US-based sterile fill-finish CDMO and 100% subsidiary of Japan-based Ajinomoto Co., Inc. Scheduled for completion in May 2025, the acquisition provides PCI with its first-ever North American manufacturing location for prefilled syringes and cartridges – including isolator technology for these formats – as well as high potent manufacturing suitable for antibody-drug conjugates (ADCs).
Article content
Althea's robust clinical- and commercial-stage services for injectable drug products augments PCI's deep industry experience, aligning with the company's global sterile fill-finish capabilities and established expertise in advanced drug delivery. In addition, Althea's substantial knowledge base, skillsets and capacity in scalable, custom oligonucleotides and peptides complements PCI's existing manufacturing capabilities in complex formulations and lyophilization across a broad range of injectables – including nanoparticles, mRNA, MABs, proteins, and other biologics for delivery formats such as vials, bottles, prefilled syringes and autoinjectors.
Article content
The acquisition also adds high potent vial filling with lyophilization, making PCI one of very few US-based CDMOs capable of producing the emerging oncology modality of antibody-drug conjugates (ADCs). Building upon PCI's legacy in high potent molecules, the strategy creates an end-to-end offering for clients via specialized capabilities across the globe, and broadens its biologics development and manufacturing leadership.
Article content
For PCI's advanced drug delivery systems and drug-device combination business, Althea's assets supplement PCI's leadership position in final device assembly and packaging facilities in both Europe and North America. Acquiring Althea's San Diego campus also makes PCI one of the largest manufacturing centers in the US West Coast's biopharma stronghold and is a natural extension of PCI's current clinical trial services and early phase robotic sterile fill-finish capabilities, creating a scalable, flexible manufacturing complex with state-of-the-art facilities within minutes of each other.
Article content
'To continue supporting the needs of our customers in their endeavors to bring life-changing therapies to patients, PCI continues to make sizable investments in the sterile fill-finish category that bring additional capabilities, capacity and technologies into our portfolio,' said Salim Haffar, CEO of PCI Pharma Services. 'Welcoming Althea into the PCI family expands our capabilities to support several therapeutic and drug delivery modalities, including the emerging ADC marketplace, and complements our broad end-to-end solutions alongside clinical trial services and advanced drug delivery.'
Article content
PCI is a world-leading CDMO, providing clients with integrated end-to-end drug development, manufacturing and packaging capabilities that increase their products' speed to market and opportunities for commercial success. PCI brings the proven experience that comes with more than 90 successful product launches each year and over five decades in the healthcare services business. The company currently has 30 sites across seven countries (Australia, Canada, U.S., Ireland, Wales, Germany and Spain), and over 7,000 employees working to bring life-changing therapies to patients.
Article content
Article content
Leading technology and continued investment enable PCI Pharma Services to address global drug development needs throughout the entire product life cycle – from manufacturing capabilities through the clinical trial supply chain and commercialization. Its clients utilize PCI as an extension of their business, and a collaborative partner with the shared goal of improving patients' lives. For more information, visit pci.com.
Article content
Article content
Article content
Article content
Article content
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Winnipeg Free Press
25 minutes ago
- Winnipeg Free Press
Senator says U.S. tariffs from Trump White House damaging for Washington state
Opponents from Washington state of U.S. President Donald Trump's tariff threats against Canada are vowing to fight, saying the ongoing trade war has delivered a heavy blow to American border communities. In a conference call led by Democrat U.S. Senator Patty Murray that included British Columbia Premier David Eby, Murray said regions such as Whatcom County bordering Canada get about 12 per cent of taxable retail income from Canadian consumers. Murray said the drop in Canadian tourists visiting her state has also resulted in economic uncertainty among ferry operators and in Point Roberts, where residents cannot access the U.S. mainland without travelling through Canada. Eby said it is difficult to continue asking British Columbians to keep their money in Canada but the U.S. boycotts are necessary in the trade war despite circumstances being 'miserable' on both sides of the border. Earlier this week, Eby responded to statements by the U.S. Ambassador to Canada who called Canadians mean and nasty over their travel and alcohol boycott, saying Canadians would be 'proud' to be considered mean for standing up for their sovereignty. Edmund Schweitzer, founder of Washington-based digital device maker Schweitzer Engineering Laboratories, said during the conference call that his company is predicting the tariffs will cost it US$100 million in 'unanticipated federal taxes.' Schweitzer said that means each of the 7,000 employees who co-own the company will take a financial hit of US$14,000 from the tariffs. 'President Trump seems to have created the 51st state that he was talking about, which is the great state of uncertainty,' he said Wednesday. 'And this is affecting all of us.' Murray said she is working in the U.S. Congress to bring Democrats and Republicans to join in the fight to wrestle back the power to set tariffs from the White House and urges other Americans to join the cause. 'Who is responsible for this, and we all need to remember this, is the president of the United States who started this,' Murray said. 'We are raising our voices to say, 'Enough is enough … stop this.' Wednesdays Columnist Jen Zoratti looks at what's next in arts, life and pop culture. B.C. is among several Canadian provinces that banned the sale of U.S. alcohol from government-run stores after the trade war began, and industry groups say such sales in Canada have fallen sharply in March and April. Statistics Canada figures show the number of Canadians returning home by car from south of the border fell to just over 33 per cent in June compared with the same period last year, and return trips by air fell to just over 22 per cent during the same period. 'No one wants this,' Murray said of the falling numbers and economic uncertainty. 'We did not ask for this. It's been imposed on us. And I think that the premier is making it clear he has to make it painful for the United States. 'That doesn't change our relationship with British Columbia. We've always been friends, allies. We have had challenges in the past, but we talk to each other. We work through it, and that's what we both want at the end of this.' This report by The Canadian Press was first published July 23, 2025.
Edmonton Journal
an hour ago
- Edmonton Journal
CF Montreal pledges rebuild in open letter
Article content MONTREAL — CF Montreal has started its rebuild quickly. Article content The Major League Soccer club announced Wednesday that it has acquired 21-year-old defender Efrain Morales from Atlanta United in return for US$450,000 in 2025 general allocation money (GAM) and $350,000 in conditional GAM. Article content Atlanta would also retain a percentage of a future transfer involving Morales Article content Article content The move came hours after club executives published an open letter to fans that acknowledged the team's shortcomings and stated the club would begin a new chapter rooted in ambition, pride and winning. Article content Article content President and CEO Gabriel Gervais, managing director of recruitment and sporting methodology Luca Saputo and managing director of academy strategy and roster management Simone Saputo signed the letter. Montreal is currently languishing at the bottom of the MLS with a 3-15-6 record — for 15 points in 24 games — and dropped out of the Canadian Championship with a quarterfinal loss to lower-tier Forge FC of the Canadian Premier League in a bleak season. Article content The letter said supporters would see concrete steps toward a rebuild in the upcoming transfer windows. The MLS summer window, which allows clubs to sign players plying their trades in other countries, opens Thursday. Article content Article content Montreal had the league's lowest payroll last season. Morales is making $112,019 this year, according to the website Article content Morales began his professional career in 2020 with Atlanta United 2, where he had three goals and an assist over three USL Championship seasons and three MLS Next Pro seasons. Article content He made his MLS debut with Atlanta in a 3-0 victory over the Charlotte Independence in the fourth round of the U.S. Open Cup on May 7, 2024. Article content Over two MLS seasons, Morales has played 648 minutes over nine games and picked up one assist. He also played in three U.S. Open Cup games. Article content 'We have not met the standards we set for ourselves, nor those you have the right to expect. That is why we felt the need to communicate with you directly today. Article content We share your dissatisfaction with the Club's results, and it is our responsibility to build a winning team that we can all be proud of. Article content That is why we have decided to undertake a rebuild and launch a new chapter at CF Montreal. A chapter based on ambition and pride. A new era with victory at the heart of our sporting ambitions, while also honouring our rich history and the connection with you, our 12th player. Article content We know that trust is regained through actions. As such, during the upcoming transfer windows, you will see concrete steps, a committed team, and strong initiatives aimed at rebuilding, together, a Club that deserves your loyalty.'
The Market Online
an hour ago
- The Market Online
@ the Bell: Cautious gains for Canada as trade talks spark optimism
Canada's main stock index saw its third day of minute growth on Wednesday, as optimism grew in the US over potential trade agreements with its partners. This followed a deal with Japan that shielded Tokyo from new tariffs in return for a US$550-billion commitment in American-bound investments and loans. Even so, the TSX hit a new intraday record high. Meanwhile, hopes for a US-EU trade deal rose after President Trump announced on Tuesday that European Union officials would arrive for negotiations the following day. The Dow is a stone's throw from another record high. The Canadian dollar traded for 73.52 cents US compared to 73.50 cents US on Tuesday. US crude futures traded $0.15 higher at US$65.46 a barrel, and the Brent contract rose $0.11 to US$68.70 a barrel. The price of gold was down US$40.93 to US$3,388.93. In world markets, the Nikkei was up 1,396.40 points to ¥41,171.32, the Hang Seng was up 408.04 points to HK$25,538.07, the FTSE was up 37.68 points to ₤9,061.49, and the DAX was up 198.92 points to €24,240.82. Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here .
